Inhibition of the pore-forming protein perforin by a series of aryl-substituted isobenzofuran-1(3H)-ones
-
Add time:08/24/2019 Source:sciencedirect.com
An aryl-substituted isobenzofuran-1(3H)-one lead compound was identified from a high throughput screen designed to find inhibitors of the lymphocyte pore-forming protein perforin. A series of analogs were then designed and prepared, exploring structure–activity relationships through variation of 2-thioxoimidazolidin-4-one and furan subunits on an isobenzofuranone core. The ability of the resulting compounds to inhibit the lytic activity of both isolated perforin protein and perforin delivered in situ by intact KHYG-1 natural killer effector cells was determined. Several compounds showed excellent activity at concentrations that were non-toxic to the killer cells. This series represents a significant improvement on previous classes of compounds, being substantially more potent and largely retaining activity in the presence of serum.
We also recommend Trading Suppliers and Manufacturers of 6-BROMO-3 H-ISOBENZOFURAN-1-ONE (cas 19477-73-7). Pls Click Website Link as below: cas 19477-73-7 suppliers
Prev:Pd/C-mediated synthesis of (Z)-3-alkylidenephthalides of potential pharmacological interest
Next:Synthesis of a cyanoethylidene derivative of 3,6-anhydro-d-galactose and its application as glycosyl donor) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Pd/C-mediated synthesis of (Z)-3-alkylidenephthalides of potential pharmacological interest08/23/2019
- Efficient PhB(OH)2-catalyzed one-pot synthesis of 3-substituted isoindolin-1-ones and isobenzofuran-1(3H)-ones under solvent free conditions08/22/2019
- Original articleImproved preparation of (1S,3′R,4′S,5′S,6′R)-5-chloro-6-[(4-ethylphenyl)methyl]-3′,4′,5′,6′-tetrahydro-6′-(hydroxymethyl)-spiro[isobenzofuran-1(3H),2′-[2H]pyran]-3′,4′,5′-triol08/21/2019
- TBAI-mediated regioselective 5-exo-dig iodinative oxocyclization of 2-alkynylbenzamides for the synthesis of isobenzofuran-1-imines and isobenzofurans08/20/2019


